1591 – 1600 of 2245
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
-
Mark
Development of draft validation criteria for a soluble biomarker to be regarded as a valid biomarker reflecting structural damage endpoints in rheumatoid arthritis and spondyloarthritis clinical trials
(
- Contribution to journal › Article
-
Mark
Modulation of the inflammatory response by estrogens with focus on the endothelium and its interactions with leukocytes.
(
- Contribution to journal › Scientific review
-
Mark
Recombinant human anti-transforming growth factor beta 1 antibody therapy in systemic sclerosis - A multicenter, randomized, placebo-controlled phase I/II trial of CAT-192
(
- Contribution to journal › Article
-
Mark
Autonomic and orthostatic dysfunction in primary Sjögren's syndrome
(
- Contribution to journal › Article
-
Mark
Blocking of experimental arthritis by cleavage of IgG antibodies in vivo
(
- Contribution to journal › Article
-
Mark
Gene-environment interactions in the aetiology of systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
The challenge of managing patients with polyarteritis nodosa.
(
- Contribution to journal › Scientific review
-
Mark
Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: data from an international inception cohort
(
- Contribution to journal › Article
-
Mark
C4b-binding protein and factor h compensate for the loss of membrane-bound complement inhibitors to protect apoptotic cells against excessive complement attack
(
- Contribution to journal › Article
-
Mark
Effects of Alzheimer's peptide and alpha 1-antichymotrypsin on astrocyte gene expression
(
- Contribution to journal › Article